Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

CorWave LVAS FIH Study

NCT: NCT06907017 · RECRUITING

NCT IDNCT06907017
StatusRECRUITING
Start Date2025-05-06
Completion2028-05
SponsorCorWave (INDUSTRY)
First posted
Last updated

Brief Summary

The study is a prospective, multi-center, non-randomized trial to evaluate the safety and effectiveness of the CorWave LVAS for the treatment of advanced heart failure patients.

Frequently Asked Questions

What is CorWave LVAS FIH Study?

CorWave LVAS FIH Study is a clinical trial registered under NCT06907017. Current status: RECRUITING.

What is the status of NCT06907017?

The current status of NCT06907017 (CorWave LVAS FIH Study) is: RECRUITING.

When did CorWave LVAS FIH Study start?

CorWave LVAS FIH Study started on 2025-05-06.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.